Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011

1
Aarkstore.com Breast Cancer Vaccines and
Therapeutic Antibodies Pipeline, 2011
2
Summary

• The breast cancer immunotherapy pipeline is
  showing rapid development. This report presents
  findings on more than 30 candidate therapies,
  including 22 therapeutic vaccines and 11
  antibodies. Of the 22 vaccines in development, 7
  (32) are at clinical phases II III. Drugs
  used to treat breast cancer fall into three main
  groups hormonal blockers, chemotherapeutic
  agents and targeted antibodies. While these
  provide important treatment options for patients,
  their limitations (drug resistance, poor efficacy
  and side effects) have focused efforts on
  developing safer and more effective targeted
  therapies. Currently, the greatest growth in this
  field is in the development of breast cancer
  immunotherapies therapeutic vaccines and
  antibodies. This report presents a
  comprehensive review of the breast cancer
  immunotherapy pipeline, covering new candidate
  vaccines and antibodies. Currently, there are
  more than 20 candidate breast cancer vaccines in
  the pipeline. These include selective candidates,
  developed to target breast cancer and others,
  that are being evaluated against a number of
  cancer types, including breast cancer. This
  report also covers current developments on 11
  antibodies, some of which are new molecules
  developed to selectively target breast cancer and
  others, that are being evaluated for a number of
  cancers, including breast cancer.

3
Table of Contents

• Report ContentsDue to the nature of this
  report, details (name of candidate vaccine or
  therapeutic antibody, together with their
  respective antigen or target) in this report
  contents page, have been omitted. Executive
  SummaryChapter 1 Background p.7 1. Breast
  Cancer1.1 Statistics1.2 Diagnosis1.3
  Staging1.4 Current Treatments1.5 This
  ReportChapter 2 Breast Cancer Immunotherapy
  Strategies p.12 2.1 Vaccines Antibodies

4
More Related Reports

•   VEGF Inhibition Therapy-Indicating and
  Prognostic Biomarkers, 2011
•   Biomarkers in Alzheimers Disease, 2011
•   Alzheimers Disease Autoantibodies, Vaccines
  and Therapeutic Antibodies Pipeline, 2011
•   Prostate Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Breast Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Alzheimers Disease Biomarkers in Cerebrospinal
  Fluid and Blood, 2011
•   Image-Based Biomarkers in Alzheimers Disease,
  2011
•   Lung Cancer Vaccines and Therapeutic
  Antibodies Pipeline, Strategies and Clinical

5
For More details

• http//www.aarkstore.com/reports/Breast-Cancer-Vac
  cines-and-Therapeutic-Antibodies-Pipeline-2011-146
  442.html
• Vina
• Aarkstore.com
• Contact Marketing team
• Mob.No.918149852585
• Email enquiry_at_aarkstore.com
• URL http//www.aarkstore.com/
• XML http//www.aarkstore.com/feeds/Biopharmrepor
  ts.xml